Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 274 No 7343 p403
2 April 2005


Society summary


Eight candidates contest Scottish Executive election

Eight candidates are contesting this year’s election of six members of the Scottish Department Executive of the Royal Pharmaceutical Society. They include all six of the retiring executive members — Christine Bond, Michele Caldwell, Christine Gilmour, Rose Marie Parr, David Thomson and Angela Timoney — who are joined in the election by David Dalglish and Josie Johnston

We have been supplied with the following biographies of the candidates for election to the Scottish Executive. Voting papers will be circulated to all members of the Society with registered addresses in Scotland and must be returned by 4pm on Friday 6 May 2005.

Christine Bond, BPharm, FRPharmS, PhD, HonMFPHM, has worked for Glaxo Research Laboratories, had extensive locum community pharmacist experience and is now professor of Primary Care, University of Aberdeen, with interests in the contribution of pharmacy to effective use of medicines (prescribed and over-the-counter) and the wider health care agenda. She is part time consultant in pharmaceutical public health (NHS Grampian), editor of The International Journal of Pharmacy Practice, a committee member of the Society’s Aberdeen and North Eastern Scottish branch and a member of the Scottish Executive since 1999.

Michele Stewart Caldwell, BSc(Hons), MSc, MRPharmS, graduated from Strathclyde University in 1979 and undertook a postgraduate MSc in clinical pharmacy, graduating in 1982, while working in Glasgow Royal Infirmary. She moved to Ayrshire and Arran in 1982 and has held a variety of hospital pharmacy posts since then. She is currently director of pharmacy for NHS Ayrshire and Arran, which embraces community pharmacy, hospital pharmacy, pharmaceutical public health and prescribing advice across the local NHS system. She is a member (currently chairman) of the area pharmacy professional committee. Her specific professional interests include the use of information technology to support pharmaceutical care.

David John Dalglish, BSc(Hons), BA(Hons), MBA, MRPharmS, registered in 1971. He is currently head of pharmacy for NHS Borders, and was previously a community pharmacy owner for 25 years. His present positions include membership of the clinical executive of NHS Borders, Borders Area Pharmaceutical Committee, Association of Scottish Chief Pharmacists primary care group (honorary secretary) and the National Prescribing Information Group. He is a past member of the Society’s Council from 1974 to 1983, a past chairman of the Society’s Agricultural and Veterinary Pharmacists Group and several Council committees, a past member of the Scottish Executive, a past chairman of the Society’s Dundee and South East of Scotland and East Cumberland branches and a past president and treasurer of the British Pharmaceutical Students Association.

Christine Gilmour, MRPharmS, MBA, registered in 1985. She is chief pharmacist, NHS Lanarkshire Acute Hospitals, since 2000. She has been chairman of the Association of Scottish Chief Pharmacists since 2003, was a co-opted member of the Society’s Scottish Executive in 2004-05 and has been a member of Guild of Healthcare Pharmacists council since 2004. She was trust chief pharmacist, Hairmyres Hospital NHS Trust, 1993–2000, pharmacy prescribing adviser/community services pharmacist, Forth Valley Health Board, 1990–2000, clinical pharmacist, Woodilee Hospital, Glasgow, 1990, community pharmacist, Lloyds Pharmacy, Hatfield, Hertfordshire, 1988–90, and community pharmacist, Munro Pharmacy, Glasgow, 1986–88.

Josephine Falconer Johnston (née Drake), BSc, DipComClinPharm, MRPharmS, of Dundee, aged 50, registered in 1977. She has been practice pharmacist, NHS Tayside, since 2000 and is a visiting lecturer, extended nurse prescribing course, University of Dundee. She is a member of Tayside Pharmacy Practices Committee, Tayside Area Pharmaceutical Committee (since February 2005) and Tayside coronary heart disease managed clinical network advisory group. She is currently undertaking a supplementary prescribing course. She was previously a manager/ preregistration tutor for Lloyds Pharmacy, 1997–2001.

Rose Marie Parr, BSc(Hons), MSc, MRPharmS, is director of pharmacy for NHS Education for Scotland and director of the Centre for Post Qualification Pharmaceutical Education for NHS pharmacists in Scotland. She has been in this post since March 1993. Previous posts include principal clinical pharmacist in the Forth Valley Health Board area and posts in hospital pharmacy in the Lanarkshire Health Board area. She is a member of the Association of Medical Education in the UK and Europe. She is designated a national specialist in post qualification pharmaceutical education. She is currently chairman of the National Pharmaceutical Forum and vice-chairman of the Society’s Scottish Executive.

David Alexander McGillivray Thomson, BScPharm, MRPharmS, a graduate of Robert Gordon University, registered in 1977. He has a community pharmacy background and is now director of pharmacy, Primary Care Division, Greater Glasgow. He is a member of: the Scottish Executive (immediate past chairman); Greater Glasgow Area Pharmaceutical Committee; ACPP; Guild of Healthcare Pharmacists; the Society’s Glasgow and West Scotland branch, (past chairman and current branch public relations officer); National Pharmaceutical Forum; Association of Scottish Chief Pharmacists (chairman, primary care group); Society’s Devolution Review Working Group. He is a past member of the Post Qualification Education Board for Scotland; and a past SCPPE national tutor. His hobbies include wine appreciation, watching gardening and rugby.

Angela Timoney, MSc, MPH, MRPharmS, is currently a consultant in pharmaceutical public health with NHS Tayside. She has been in this post since 1999. She is chairman of the Society’s Scottish Executive and vice-chairman of the Scottish Medicines Consortium and the National Pharmaceutical Forum. Her interests are in the implementation of evidence based practice and patient/public involvement.

Back to Top


©The Pharmaceutical Journal